Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CyDex Pharmaceuticals Inc.

Division of Ligand Pharmaceuticals Inc.

Latest From CyDex Pharmaceuticals Inc.

Leon-Nanodrugs Appoints CEO

Leon-Nanodrugs, a nanotechnology-based drug development company, has named Theron Odlaug CEO of Leon-Nanodrugs GmbH. in Germany and Leon-Nanodrugs, Inc in the US. Odlaug has more than 35 years of experience in the biopharmaceutical industry and joins Leon-Nanodrugs from Cedarburg Pharmaceuticals where he was executive chair. Previously, he was the executive chair and CEO of Planet Biopharmaceuticals and CEO of CyDex Pharmaceuticals, Inc.

Germany Companies

Ligand captures another Captisol partner in melphalan deal with Spectrum

Ligand Pharmaceuticals earned a $3 million license fee and may receive more than $50 million in milestone payments plus double-digit royalties from Spectrum Pharmaceuticals for its Captisol-enabled melphalan - giving Ligand more than a dozen partnered programs for technology that the San Diego-based company acquired just two years ago.


New Anti-Epileptic Drug Formulations Try To Overcome Tolerability Problems

Much of the drug development activity in epilepsy is focused on improving the existing treatments.

BioPharmaceutical Clinical Trials

Executive changes at Planet Biopharmaceuticals

Planet Biopharmaceuticals, a privately-held speciality pharmaceutical company focused on providing products for allergy and asthma sufferers, has appointed Dr Theron Odlaug executive chairman and CEO effective 29 August, replacing William Goldberg who has joined MediMedia USA as CEO. Mr Goldberg will remain on Planet's board of directors. Dr Odlaug most recently served as president and CEO of CyDex Pharmacueticals.

Immune Disorders Respiratory
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • CyDex Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ligand Pharmaceuticals Inc.
  • Senior Management
  • Allen K Roberson, CFO
    Richard G White, VP, Bus. Dev. & Mktg.
  • Contact Info
  • CyDex Pharmaceuticals Inc.
    Phone: (913) 685-8850
    10513 W. 84th Terrace
    Lenexa, KS 66214